Markerstudy boss Spencer hails “momentous milestone” as FCA approves Atlanta deal

Kevin Spencer, Markerstudy

The merger between Markerstudy and Atlanta, the personal lines broking business of The Ardonagh Group, has been approved by the Financial Conduct Authority.

After the Competition and Markets Authority greenlit the deal on 26 March 2024, the FCA rubber stamped it on Friday, 31 May, six months after the proposed £1.2bn merger was first announced in September 2023.

The deal had been trailed in May at the 2023 British Insurance Brokers’ Association conference. 

RelatedMarkerstudy and Ardonagh Retail in merger talks 

Markerstudy and Ardonagh's personal lines business are in talks over a deal, Insurance Age understands.

On completion, the combined business

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

QBE unveils QCyberProtect

QBE Insurance has launched QCyberProtect, describing it as a comprehensive and globally consistent cyber policy designed to enhance cyber resilience for a range of clients worldwide.

Government starts discount rate review

The Ministry of Justice has confirmed the start of the 2024 review of the personal injury discount rate in England and Wales with a decision due no later than 11 January 2025.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: